Kamyar Shameli: Understanding the Coagulation Cascade – How Anticoagulants Prevent Blood Clots
Kamyar Shameli, Senior Scientist at Technical University of Munich, shared a post on LinkedIn:
“Understanding the Coagulation Cascade: How Anticoagulants Prevent Blood Clots
Description: The blood coagulation cascade is a precise, multi-step enzymatic process designed to prevent blood loss while keeping blood flowing safely through our vessels. At the center of this cascade is a critical turning point where multiple pathways converge: Factor Xa and Thrombin.
Here is how the coagulation cascade works and how anticoagulant therapies interrupt it:
The Conversion Mechanism
When coagulation is activated, Factor Xa converts Prothrombin into active Thrombin. Thrombin serves as the central key enzyme that drives the formation of Fibrin, creating a structural mesh that locks red blood cells and platelets into a stable clot.
How Anticoagulants Work: Anticoagulants interrupt this cascade by targeting key enzymes:
Direct Factor Xa Inhibitors amp; Direct Thrombin Inhibitors: Bind directly to Factor Xa or Thrombin to block their activity.
Heparin amp; Antithrombin Complex: Potentiate the bodys natural antithrombin mechanisms to neutralize Factor Xa and Thrombin.
Clinical Outcome
By reducing Factor Xa and Thrombin activity, fibrin formation drops significantly. This reduces the bodys ability to form and extend pathologically stable blood clots, helping prevent conditions like deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Nov 19, 2026, 16:27263 PolyU Students and Staff Unite to Donate Blood – Hong Kong Red Cross Blood Transfusion Service
-
Nov 19, 2026, 16:16Billy Otieno: The Future of Blood Donation Lies Beyond Collection
-
Nov 19, 2026, 15:58Hema Goyal: Hematocon 2026 Bringing Together Knowledge, Innovation and Excellence in Hematology
-
Nov 19, 2026, 15:44Chukwuemeka Amarachi: Understanding Complex Blood Grouping Beyond Routine ABO And RhD Typing
-
Nov 19, 2026, 14:19Long-Read Sequencing Is Closing Diagnostic Gaps in Inherited Bleeding Disorders
-
Nov 19, 2026, 13:36Raja Prince: Protein S Silencing and the Future of Hemostatic Therapy
-
Nov 19, 2026, 13:26M. Sekip Altunkan: The Thrombotic Risk of Andexanet Alfa
-
Nov 19, 2026, 13:18Felice Gragnano: Personalizing Antiplatelet Therapy After PCI
-
Nov 19, 2026, 13:11When Postpartum Warning Signs Are Ignored – National Blood Clot Alliance